Quaker Houghton's Q4 2024 performance saw a 5% decrease in net sales to $444.1 million and a decline in net income to $14.2 million. Despite a challenging macro environment, the company improved profitability and generated strong cash flow for the full year, driven by new business wins, particularly in Asia/Pacific.
Net sales for Q4 2024 decreased by 5% to $444.1 million, primarily due to lower selling prices and product mix, unfavorable foreign currency translation, and a decline in organic sales volumes.
Net income attributable to Quaker Chemical Corporation for Q4 2024 was $14.2 million, or $0.81 per diluted share, down from $20.2 million, or $1.12 per diluted share, in Q4 2023.
Non-GAAP net income for Q4 2024 was $23.6 million, or $1.33 per diluted share, compared to $31.9 million, or $1.78 per diluted share, in the prior year period.
Adjusted EBITDA for Q4 2024 was $64.8 million, a decrease of approximately 16% compared to $77.0 million in Q4 2023, mainly due to the decline in sales and operating margins.
Quaker Houghton anticipates sustained growth and share gains in 2025 by advancing its enterprise strategy, refocusing on customer intimacy, and effectively allocating capital. The company expects to deliver revenue, adjusted EBITDA, and earnings growth in 2025.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance